Intellectual Property India Publishes Patent Application for 'Repressor Fusion Protein Systems' Filed by Scribe Therapeutics Inc.

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517097182 A) filed by Scribe Therapeutics Inc., Alameda, U.S.A., on Oct. 8, for 'repressor fusion protein systems.'

Inventor(s) include Fernandes, Jason; Higgins, Sean; Denny, Sarah; White, Ross; Oakes, Benjamin; Charles, Emeric Jean Marius; Wright, Addison; Staahl, Brett T.; and Deiter, Fred.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are gene repressor systems comprising repressor fusion proteins, such as repressor fusion proteins comprising DNA binding proteins, in some cases catalytically dead CRISPR proteins and guide nucleic acids (gRNA), useful in the repression of genes. Also provided are methods of using such systems to repress transcription of genes."

The patent application was internationally filed on Mar. 28, 2024, under International application No.PCT/US2024/021866.

Disclaimer: Curated by HT Syndication.